TNXB - tenascin XB Gene
Also Known as XB; TNX; XBS; EDS3; HXBL; TENX; TN-X; VUR8; TNXB1; TNXB2; TNXBS; EDSCLL; EDSCLL1
Species: Homo sapiens
About TNXB
This gene has 11 transcripts (splice variants), 1 gene allele, 263 orthologues, 25 paralogues and is associated with 5 phenotypes. Broad expression in adrenal (RPKM 35.5), fat (RPKM 21.3) and 17 other tissues.
Summary
This gene encodes a member of the tenascin family of extracellular matrix glycoproteins. The tenascins have anti-adhesive effects, as opposed to fibronectin which is adhesive. This protein is thought to function in matrix maturation during wound healing, and its deficiency has been associated with the connective tissue disorder Ehlers-Danlos syndrome. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. It is one of four genes in this cluster which have been duplicated. The duplicated copy of this gene is incomplete and is a pseudogene which is transcribed but does not encode a protein. The structure of this gene is unusual in that it overlaps the CREBL1 and CYP21A2 genes at its 5' and 3' ends, respectively. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
TNXB Products (3)
| mRNA | Protein | Name |
|---|---|---|
| NM_001365276.2 | NP_001352205.1 | tenascin-X isoform 3 precursor |
| NM_019105.8 | NP_061978.6 | tenascin-X isoform 1 precursor |
| NM_032470.4 | NP_115859.2 | tenascin-X isoform 2 |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables collagen fibril binding |
IDA
IDA: Inferred from direct assay
|
16278880 | GOA |
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
21516116 | GOA |
| Biological Process GO Annotation | Evidence | References | Source |
|---|---|---|---|
| involved in collagen metabolic process |
IMP
IMP: Inferred from mutant phenotype
|
15102077 | GOA |
| involved in elastic fiber assembly |
IMP
IMP: Inferred from mutant phenotype
|
15102077 | GOA |
| involved in positive regulation of collagen fibril organization |
IDA
IDA: Inferred from direct assay
|
17033827 | GOA |
TNXB Protein Structure
hEGF: Human growth factor-like EGF (232 - 244)
hEGF: Human growth factor-like EGF (264 - 275)
hEGF: Human growth factor-like EGF (295 - 306)
hEGF: Human growth factor-like EGF (326 - 337)
hEGF: Human growth factor-like EGF (449 - 461)
hEGF: Human growth factor-like EGF (512 - 523)
hEGF: Human growth factor-like EGF (542 - 554)
fn3: Fibronectin type III domain (755 - 829)
fn3: Fibronectin type III domain (842 - 914)
fn3: Fibronectin type III domain (1066 - 1135)
fn3: Fibronectin type III domain (1163 - 1233)
fn3: Fibronectin type III domain (1266 - 1342)
fn3: Fibronectin type III domain (1377 - 1446)
fn3: Fibronectin type III domain (1478 - 1548)
fn3: Fibronectin type III domain (1581 - 1645)
fn3: Fibronectin type III domain (1679 - 1743)
fn3: Fibronectin type III domain (1781 - 1847)
fn3: Fibronectin type III domain (1885 - 1955)
fn3: Fibronectin type III domain (1991 - 2061)
fn3: Fibronectin type III domain (2100 - 2169)
fn3: Fibronectin type III domain (2199 - 2269)
fn3: Fibronectin type III domain (2307 - 2378)
fn3: Fibronectin type III domain (2416 - 2485)
fn3: Fibronectin type III domain (2527 - 2596)
fn3: Fibronectin type III domain (2632 - 2707)
fn3: Fibronectin type III domain (2741 - 2810)
fn3: Fibronectin type III domain (2848 - 2923)
fn3: Fibronectin type III domain (2957 - 3026)
fn3: Fibronectin type III domain (3064 - 3135)
fn3: Fibronectin type III domain (3171 - 3240)
fn3: Fibronectin type III domain (3266 - 3331)
fn3: Fibronectin type III domain (3359 - 3433)
fn3: Fibronectin type III domain (3453 - 3519)
fn3: Fibronectin type III domain (3562 - 3630)
fn3: Fibronectin type III domain (3659 - 3737)
fn3: Fibronectin type III domain (3758 - 3833)
fn3: Fibronectin type III domain (3847 - 3920)
fn3: Fibronectin type III domain (3935 - 4007)
Fibrinogen_C: Fibrinogen beta and gamma chains, C-terminal globular domain (4027 - 4234)
- 0
- 700
- 1400
- 2100
- 2800
- 3500
- 4244 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
tenascin-X |
|
TNXB Antibodies
| Cat. No. | 상품명 | 신청 | Reactivity |
|---|---|---|---|
| HY-P81492 | TN-X Antibody (YA1237) | IHC-P | Human |
| HY-P81492A | TN-X Antibody (YA1237)(PBS only) | IHC-P | Human |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Ehlers-Danlos Syndrome, Classic-Like |
|
|
| Vesicoureteral Reflux 8 |
|
|
| Familial Vesicoureteral Reflux |
|
|
| Adrenal Hyperplasia, Congenital, Due To 21-Hydroxylase Deficiency |
|
|
| Lipoid Congenital Adrenal Hyperplasia |
|
|
| Ehlers-Danlos Syndrome, Hypermobility Type |
|
|
| Ehlers-Danlos Syndrome |
|
|
| Hypermobility Syndrome |
|
|
| Hypermobile Ehlers-Danlos Syndrome |
|
|
| Classic Ehlers-Danlos Syndrome |
|
|
| Vesicoureteral Reflux |
|
|
| Ureteric Orifice Cancer |
|
|
| Collagen Disease |
|
|
| Stickler Syndrome, Type I |
|
|
| Tibialis Tendinitis |
|
|
| Steroid Inherited Metabolic Disorder |
|
|
| Caspase 8 Deficiency |
|
|
| Connective Tissue Disease |
|
|
| End Stage Renal Disease |
|
|
| Aortic Aneurysm, Familial Abdominal, 1 |
|
|
| Postural Orthostatic Tachycardia Syndrome |
|
|
| Capillary Malformations, Congenital |
|
|
| Ullrich Congenital Muscular Dystrophy 1 |
|
|
| Osteogenesis Imperfecta, Type Ii |
|
|
| Orthostatic Intolerance |
|
|
| Loeys-Dietz Syndrome |
|
|
| Cakut |
|
|
| Brittle Bone Disorder |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Canis familiaris | TNXB | VGNC | VGNC:47704 |
| Rattus norvegicus | TNXB | RGD | RGD:1594402 |
| Mus musculus | TNXB | MGD | MGI:1932137 |
| Macaca mulatta | TNXB | VGNC | VGNC:99451 |
| Bos taurus | TNXB | VGNC | VGNC:36211 |
| Others | TNXB | NCBI |